¼¼°èÀÇ ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)
Global Medical Oxygen Concentrators Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
¼¼°è ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀå ±Ô¸ð´Â 2023³â 55¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇϰí, 2024-2032³â ¿¬Æò±Õ 7.6% ¼ºÀåÇÏ¿© 2032³â¿¡´Â ¾à 106¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÇ·á¿ë »ê¼Ò¹ß»ý±â´Â È£Èí±â ÁúȯÀ» ¾Î°í Àְųª º¸Á¶ »ê¼Ò ¿ä¹ýÀÌ ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ÁýÁßÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇϱâ À§ÇØ Æ¯º°È÷ °í¾ÈµÈ ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ ÀåÄ¡´Â ÁÖº¯ °ø±â¸¦ ÈíÀÔÇÏ°í ´Ù¸¥ °¡½º¸¦ Á¦°ÅÇÏ¿© ȯÀÚ¿¡°Ô °í³óµµÀÇ »ê¼Ò¸¦ °ø±ÞÇÕ´Ï´Ù.
½ÃÀå ¿ªÇÐ
ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ µÞ¹ÞħµÇ°í ÀÖÀ¸¸ç, COPD ¹× õ½Ä°ú °°Àº È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÇÔ²² Àü ¼¼°è Àα¸ÀÇ °í·ÉȰ¡ ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. »ê¼Ò ¿ä¹ýÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ³óÃà±â ¼³°è¸¦ °³¼±ÇÏ´Â ±â¼ú ¹ßÀü, ÀçÅà °£È£ ȯ°æ¿¡ ´ëÇÑ ¼±È£µµ°¡ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, COVID-19 ÆÒµ¥¹ÍÀº »ê¼Ò ¿ä¹ý¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̰í ÀÇ·á ½Ã¼³°ú °¡Á¤ ¸ðµÎ¿¡¼ ÀÇ·á¿ë »ê¼Ò¹ß»ý±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÁõÆø½Ã۰í ÀÖ½À´Ï´Ù. Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê, ÀÇ·áºñ Áõ°¡, »ýȰ½À°ü º¯È ¹× ȯ°æÀû ¿äÀΰú °°Àº ¼¼°è °Ç° µ¿ÇâÀº ½ÃÀå Çü¼º¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â¼ú ¹ßÀü, Àú·ÅÇÑ °¡°Ý, ÀÇ·á ÀÎÇÁ¶ó °³¼± ³ë·ÂÀ¸·Î ÀÎÇØ ½ÅÈï ½ÃÀå¿¡¼ ÀÇ·á¿ë »ê¼Ò¹ß»ý±â äÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ÇÑÆí, ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀåÀÇ ÁøÈÇϴ ȯ°æ¿¡¼ °æÀï ¹× ±ÔÁ¦ ȯ°æ°ú °°Àº µµÀü °úÁ¦¸¦ °í·ÁÇØ¾ß ÇÕ´Ï´Ù.
Á¶»ç º¸°í¼´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀ̵˴ϴÙ. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ¼¼°è ½ÃÀå¿¡¼ °¢ ºÎ¹®À» Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á¿ë »ê¼Ò¹ß»ý±â »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù.
½ÃÀå ¼¼ºÐÈ
ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀå º¸°í¼ÀÇ ÀÌ ¼½¼Ç¿¡¼´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ »ó¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·« ´ã´çÀÚ°¡ °¢ Á¦Ç° ¹× ¼ºñ½ºÀÇ Å¸°ÙÃþÀ» ½Äº°Çϰí ÇâÈÄ ºñÁö´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
Áö¿ª ºÐ¼®
ÀÌ ¼½¼Ç¿¡¼´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °¢ ÀÀ¿ë ºÐ¾ß¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼¸¦ Á¦°ø ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå ¼¹®
Á¦2Àå ÁÖ¿ä ¿ä¾à
- ½ÃÀå ÇÏÀ̶óÀÌÆ®
- ¼¼°è ½ÃÀå ÇöȲ
Á¦3Àå ÀÇ·á¿ë »ê¼Ò¹ß»ý±â - »ê¾÷ ºÐ¼®
- ¼·Ð : ½ÃÀå ¿ªÇÐ
- ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
- ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
- ½ÃÀå ±âȸ
- ¾÷°è µ¿Çâ
- Porter's Five Forces ºÐ¼®
- ½ÃÀå ¸Å·Âµµ ºÐ¼®
Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®
- ¹ë·ùüÀÎ ºÐ¼®
- ¿øÀç·á ºÐ¼®
- ¿øÀç·á ¸®½ºÆ®
- ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
- ÁÖ¿ä ¿øÀç·á °¡°Ý µ¿Çâ
- ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
- ¸¶ÄÉÆÃ Ã¤³Î
- Á÷Á¢ ¸¶ÄÉÆÃ
- °£Á¢ ¸¶ÄÉÆÃ
- ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ
Á¦5Àå ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç° À¯Çüº°
- °³¿ä : Á¦Ç° À¯Çüº°
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- ºÐ¼® : Á¦Ç° À¯Çüº°
- °íÁ¤Çü »ê¼Ò¹ß»ý±â
- ÈÞ´ëÇü »ê¼Ò¹ß»ý±â
Á¦6Àå ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ¼¼°è ½ÃÀå ºÐ¼® : ±â¼úº°
- °³¿ä : ±â¼úº°
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- ºÐ¼® : ±â¼úº°
- ¿¬¼Ó Ç÷οì½Ä »ê¼Ò¹ß»ý±â
- ÆÞ½º Ç÷οì½Ä »ê¼Ò¹ß»ý±â
Á¦7Àå ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°
- °³¿ä : ¿ëµµº°
- ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
- ºÐ¼® : ¿ëµµº°
- ÀçÅÃÀÇ·á
- º´¿ø
- ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ(ASCs)
Á¦8Àå ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°
- Àü¸Á : Áö¿ªº°
- ¼·Ð
- ºÏ¹Ì ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ºÏ¹Ì : ºÎ¹®º°
- ºÏ¹Ì : ±¹°¡º°
- ¹Ì±¹
- ij³ª´Ù
- ¸ß½ÃÄÚ
- À¯·´ ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- À¯·´ : ºÎ¹®º°
- À¯·´ : ±¹°¡º°
- ¿µ±¹
- ÇÁ¶û½º
- µ¶ÀÏ
- ÀÌÅ»¸®¾Æ
- ·¯½Ã¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
- ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- È£ÁÖ
- µ¿³²¾Æ½Ã¾Æ
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
- ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
- ºê¶óÁú
- ¾Æ¸£ÇîÆ¼³ª
- Æä·ç
- Ä¥·¹
- ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
- °³¿ä, ½ÇÀû°ú ¿¹Ãø
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
- »ç¿ìµð¾Æ¶óºñ¾Æ
- ¾Æ¶ø¿¡¹Ì¸®Æ®
- À̽º¶ó¿¤
- ³²¾ÆÇÁ¸®Ä«°øÈ±¹
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
Á¦9Àå ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ±â¾÷ °æÀï »óȲ
- ÀÇ·á¿ë »ê¼Ò¹ß»ý±â ½ÃÀå °æÀï
- Á¦ÈÞ, Çù·Â, ÇÕÀÇ
- ÀμöÇÕº´
- ½ÅÁ¦Ç° ¹ß¸Å
- ±âŸ °³¹ß
Á¦10Àå ±â¾÷ °³¿ä
- ±â¾÷ Á¡À¯À² ºÐ¼®
- ½ÃÀå ÁýÁßµµ
- ResMed Inc.
- Philips Respironics(a Division Of Royal Philips)
- Invacare Corporation
- Inogen Inc.
- Drive DeVilbiss Healthcare
- Chart Industries
- Nidek Medical Products Inc.
- Teijin Limited
- Precision Medical Inc.
- GCE Group
ksm
The global demand for Medical Oxygen Concentrators Market is presumed to reach the market size of nearly USD 10.69 Billion by 2032 from USD 5.53 Billion in 2023 with a CAGR of 7.6% under the study period 2024 - 2032.
Medical oxygen concentrators are devices designed specifically to deliver a focused stream of oxygen to individuals with respiratory conditions or require supplemental oxygen therapy. These devices take in ambient air, remove other gases, and provide a higher concentration of oxygen to the patient.
MARKET DYNAMICS
The medical oxygen concentrators market is propelled by various factors contributing to its continual expansion. An aging global population, coupled with a rising prevalence of respiratory disorders like COPD and asthma, fuels the demand for these devices. Increased awareness of the benefits of oxygen therapy, advancements in technology enhancing concentrator design, and the preference for homecare settings further contribute to market growth. The COVID-19 pandemic has increased oxygen therapy awareness, amplifying the demand for medical oxygen concentrators both in healthcare facilities and for home use. Government initiatives, rising healthcare expenditure, and global health trends, such as lifestyle changes and environmental factors, play pivotal roles in shaping the market. Additionally, the adoption of medical oxygen concentrators is increasing in emerging markets due to technological advancements, affordability, and efforts to improve healthcare infrastructure. While these factors drive market expansion, challenges such as competition and regulatory compliance need consideration in the evolving landscape of the medical oxygen concentrators market.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of medical oxygen concentrators. The growth and trends of medical oxygen concentrators industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the medical oxygen concentrators market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product Type
- Stationary Oxygen Concentrators
- Portable Oxygen Concentrators
By Technology
- Continuous Flow Oxygen Concentrators
- Pulse Flow Oxygen Concentrators
By Application
- Home Care
- Hospitals
- Ambulatory Surgical Centers (ASCs))
REGIONAL ANALYSIS
This section covers the regional outlook, which accentuates current and future demand for the Medical Oxygen Concentrators market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Oxygen Concentrators market include ResMed Inc., Philips Respironics (a Division Of Royal Philips), Invacare Corporation, Inogen Inc., Drive DeVilbiss Healthcare, Chart Industries, Nidek Medical Products Inc., Teijin Limited, Precision Medical, Inc., GCE Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . MEDICAL OXYGEN CONCENTRATORS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . GLOBAL MEDICAL OXYGEN CONCENTRATORS MARKET ANALYSIS BY PRODUCT TYPE
- 5.1 Overview by Product Type
- 5.2 Historical and Forecast Data
- 5.3 Analysis by Product Type
- 5.4 Stationary Oxygen Concentrators Historic and Forecast Sales by Regions
- 5.5 Portable Oxygen Concentrators Historic and Forecast Sales by Regions
6 . GLOBAL MEDICAL OXYGEN CONCENTRATORS MARKET ANALYSIS BY TECHNOLOGY
- 6.1 Overview by Technology
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Technology
- 6.4 Continuous Flow Oxygen Concentrators Historic and Forecast Sales by Regions
- 6.5 Pulse Flow Oxygen Concentrators Historic and Forecast Sales by Regions
7 . GLOBAL MEDICAL OXYGEN CONCENTRATORS MARKET ANALYSIS BY APPLICATION
- 7.1 Overview by Application
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Application
- 7.4 Home Care Historic and Forecast Sales by Regions
- 7.5 Hospitals Historic and Forecast Sales by Regions
- 7.6 Ambulatory Surgical Centers (ASCs)) Historic and Forecast Sales by Regions
8 . GLOBAL MEDICAL OXYGEN CONCENTRATORS MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis
9 . COMPETITIVE LANDSCAPE OF THE MEDICAL OXYGEN CONCENTRATORS COMPANIES
- 9.1. Medical Oxygen Concentrators Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF MEDICAL OXYGEN CONCENTRATORS INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. ResMed Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Philips Respironics (a Division Of Royal Philips)
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Invacare Corporation
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Inogen Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Drive DeVilbiss Healthcare
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Chart Industries
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. Nidek Medical Products Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Teijin Limited
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Precision Medical Inc.
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. GCE Group
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies